President Donald Trump promised a coronavirus disease 2019 (COVID-19) vaccine by the end of the year; COVID-19 survivors report anxiety over reinfection; colleges release COVID-19 testing and quarantine data.
Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
Data to be presented at SLEEP 2020 showed Eisai Inc's lemborexant (DAYVIGO) had statistically significant long-term efficacy and safety compared with placebo on sleep maintenance and onset in patients with insomnia disorder, said Margaret Moline, PhD.
This week, the top managed care news included HHS defending a CDC change limiting COVID-19 testing for asymptomatic people; an inside look at the Facing Metastatic Breast Cancer Together campaign; a conversation with Dr Kashyap Patel on his new book.
Most people with systemic lupus erythematosus and inflammatory arthritis, who use medications that make them immunosuppressed, are not necessarily at greater risk of hospitalization from coronavirus disease 2019 (COVID-19), according to 2 studies.
Can muscle mass predict whether patients with chronic obstructive pulmonary disease have a longer hospital stay?
A Boxed Warning on increased risk of leg and foot amputations has been removed from the label of canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor.
Liquid CDX, a blood test, analyzes more than 300 genes and genomic signatures across all solid tumors.
Researchers explore the standard pathophysiological and molecular linkages between Parkinson disease (PD) and diabetes, as well as the role of diabetes therapies in the pathological pathways and progression of PD.
In young college-age women, migraine was associated with several sleep issues, although no differences in sleep quality were reported between migraineurs and controls, according to a recent study.
Preliminary data find Moderna's COVID-19 vaccine effective in older adults; FDA authorizes use of $5 COVID-19 rapid test; the DOJ asks for nursing home data from 4 blue states.
Through a new cost-saving provision made possible by the recent COVID-19 relief CARES Act, consumers can now utilize flexible spending arrangements and health savings accounts to purchase cost-effective over-the-counter medications.
Patients who are diagnosed with Waldenström macroglobulinemia (WM) at age 55 or younger tend to have low risk profiles and very high overall survival rates.
Two days after the CDC changed its guidance on who should get tested for SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19), HHS said the move was not politically motivated.
A 16-week trial involving children with type 1 diabetes (T1D) found glucose level was in the target range for a greater percentage of time in individuals who used a closed-loop system compared with those who used a sensor-augmented insulin pump.
The burden of disease in patients with axial psoriatic arthritis (PsA) can differ significantly between genders, according to a new study published in Modern Rheumatology.
A new opinion article suggests minimal residual disease (MRD) is not yet ready for “prime time” in the clinic, even though it’s already making a major impact on clinical trials.
Until a vaccine is available, antibody tests may offer the best way to assess risk prevalence and community spread of COVID-19.
CMS requires all nursing homes to test staff for coronavirus disease 2019; FEMA signals it may end reimbursement for personal protective equipment; CDC issues new exposure testing recommendations.
Among patients with Parkinson disease (PD), co-occurrence of dementia and hypertension, as well as duration of PD, were significantly associated with mortality due to coronavirus disease 2019 (COVID-19), according to a recent study.
Going into the COVID-19 pandemic, previous studies by Milliman found a worsening over the past 5 years of access to inpatient intermediate levels of care and office-based care, said Henry Harbin, MD, leading behavioral health expert and adviser to The Bowman Family Foundation.
Scientists say data on the coronavirus disease 2019 (COVID-19) treatment convalescent plasma may be misrepresented; Anthony Fauci, MD, warned that distributing a COVID-19 vaccine without testing in large trials could affect other vaccines; remdesivir was shown to have little effect in patients hospitalized with COVID-19.
Results from a recent study examining thirst among patients with heart failure show that most had fluid retention and close to half were frequently thirsty, which is considered troublesome in these patients.
At diagnosis, approximately 6% of breast cancers are metastatic breast cancer (MBC), which although treatable is not curable. Experts predicted that 276,480 women and 2620 men would receive such a diagnosis in 2020.
Sex may play a modifying role in the 25% of patients with Stargardt disease who carried a combination of a mild and a severe allele, according to results of a cross-sectional study published in JAMA Ophthalmology.
The FDA approved the drug on August 7, and on August 17, the European Medicines Agency (EMA) accepted the marketing authorization application for the spinal muscular atrophy (SMA) treatment.
Increased sleep need, poor sleep quality, and fatigue were found to occur more frequently and longer among patients with concussions, according to study findings.
The pathophysiology of migraine with aura in women does not involve alteration of thalamic volume, according to a study published in NeuroImage: Clinical.
The FDA issued an emergency use authorization (EUA) for convalescent plasma to treat coronavirus disease 2019 (COVID-19); limited transmission of COVID-19 was reported in reopened childcare centers; universal mask mandates could save lives.
A recent survey showed the disruption in cancer care as a result of the pandemic is worrying professionals who provide psychosocial support to patients.
